<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02525627</url>
  </required_header>
  <id_info>
    <org_study_id>H-S-045</org_study_id>
    <nct_id>NCT02525627</nct_id>
  </id_info>
  <brief_title>A Comparative Study of In-vivo Wear Between 28 mm and 40 mm Metal Heads</brief_title>
  <acronym>X3largeheads</acronym>
  <official_title>A Comparative Study of In-vivo Wear Between 28 mm and 40 mm Metal Heads With Highly Cross Linked (X3) Acetabular Polyethylene Insert in the Hemispherical Trident Cup</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker European Operations BV</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker European Operations BV</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, single centre, randomized clinical study; series of patients with a 5-years
      patient evaluation period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single centre randomized clinical outcomes study. The Symax stem or Accolade TMZF
      (Titan, Molybdenum, Zirconium, Ferrum) in combination with the Hemispherical Trident cup, X3
      inserts, 28 and 40 mm Metal heads are the primary components to be implanted for evaluation.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">January 12, 2016</completion_date>
  <primary_completion_date type="Actual">January 12, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To Compare Wear of the Polyethylene X3 Insert Based on Digital Radiographs Using the Hip Analysis Suite (HAS).</measure>
    <time_frame>5 years follow-up</time_frame>
    <description>Determine equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes using HAS, a software for the determination of polyethylene wear on digital radiographs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score (HHS) Patient Questionnaire</measure>
    <time_frame>6 weeks, 3 months, 1, 2 and 5 years</time_frame>
    <description>Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score of less than or equal to 79 is considered fair-poor. 90-100 = excellent 80-89 = good 70-79 = fair 0-69 = poor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Merle D'Aubergine Score (MdA)</measure>
    <time_frame>6 weeks, 3 months, 1, 2 and 5 years</time_frame>
    <description>The Merle D'Aubergine-Charnley Score is a simplified clinical scoring system for the hip. The overall score is determined by the sum of scores obtained from each dimension of pain, walking ability and joint mobility. The overall numeric score is given by adding the domain scores. Clinical grades: Excellent, 18, Good 15-17, Fair 13-14, Poor &lt;13.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Arthroplasty, Replacement, Hip</condition>
  <arm_group>
    <arm_group_label>Trident cup, X3 inserts, 28 mm head</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trident cup, X3 inserts, 40 mm head</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Trident cup, X3 inserts, 28 mm head</intervention_name>
    <description>Orthopaedic implant</description>
    <arm_group_label>Trident cup, X3 inserts, 28 mm head</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Trident cup, X3 inserts, 40 mm head</intervention_name>
    <description>Orthopaedic implant</description>
    <arm_group_label>Trident cup, X3 inserts, 40 mm head</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Symax stem</intervention_name>
    <description>Orthopaedic implant</description>
    <arm_group_label>Trident cup, X3 inserts, 28 mm head</arm_group_label>
    <arm_group_label>Trident cup, X3 inserts, 40 mm head</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Accolade TMZF stem</intervention_name>
    <description>Orthopaedic implant</description>
    <arm_group_label>Trident cup, X3 inserts, 28 mm head</arm_group_label>
    <arm_group_label>Trident cup, X3 inserts, 40 mm head</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and non pregnant female patients between 18-75 years of age.

          2. Patients requiring uncemented primary total hip arthroplasty (THA), suitable for the
             use of the Symax stem

          3. Patients with a diagnosis of osteoarthritis (OA), rheumatoid arthritis (RA), avascular
             necrosis (AVN) or post-traumatic arthritis (TA).

          4. Patients who understand the conditions of the study and are willing and able to comply
             with the post-operative scheduled clinical and radiographic evaluations and the
             prescribed rehabilitation

          5. Patients who signed the specific Informed Consent Form prior to surgery

        Exclusion Criteria:

          1. Patients who require revision of a previously implanted THA

          2. Patients who had a THA on contra-lateral side within the last 1 year.

          3. Patients who had a THA on contralateral side more than 1 year ago and the
             rehabilitation period outcome was considered unsatisfactory or not good. (Patients
             with contra-lateral THA &gt; 1 year ago with good outcome (Harris Hip Score &gt; 85) can be
             included in the study).

          4. Patients who will need lower limb joint replacement for another joint within one year.

          5. Bilaterally operated patient.

          6. Patients who have had a prior procedure of acetabular osteotomy.

          7. Patients with active or suspected infection.

          8. Patients with malignancy - active malignancy

          9. Patients with a diagnosed systemic disease that would affect the subject's welfare or
             overall outcome of the study (i.e. severe osteoporosis, Paget's disease, renal
             osteodystrophy) or is immunologically suppressed, or receiving steroids in excess of
             physiologic dose requirements.

         10. The patient has a neuromuscular or neurosensory deficit which would limit the ability
             to assess the performance of the device or the patient has a neurological deficit
             which interferes with the patient's ability to limit weight bearing or places an
             extreme load on the implant during the healing period.

         11. Female patients planning a pregnancy during the course of the study.

         12. Patients with systemic or metabolic disorders leading to progressive bone
             deterioration.

         13. Patients, who as judged by the surgeon, are mentally incompetent or are unlikely to be
             compliant with the prescribed post-operative routine and follow-up evaluation
             schedule.

         14. Patients with other severe concurrent joint involvements which can affect their
             outcome.

         15. Patients with other concurrent illnesses which are likely to affect their outcome such
             as sickle cell anaemia, systemic lupus erythematosus, psoriasis, Insulin dependent
             Type I diabetes or renal disease requiring dialysis.

         16. Surgeries to be performed with navigation and/or robot-assisted instruments.

         17. Patient with a known sensitivity to device materials.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ide C. Heyligers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Atrium Medical Center, Heerlen, The Netherlands</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Atrium Medical Center</name>
      <address>
        <city>Heerlen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>June 11, 2015</study_first_submitted>
  <study_first_submitted_qc>August 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2015</study_first_posted>
  <results_first_submitted>February 28, 2018</results_first_submitted>
  <results_first_submitted_qc>March 5, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">March 6, 2019</results_first_posted>
  <last_update_submitted>March 5, 2019</last_update_submitted>
  <last_update_submitted_qc>March 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>40 participants/hips - 6 participants/hips excluded during surgery = 34 participants/hips</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Trident Cup, X3 Inserts, 28 mm Head</title>
          <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 28 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
        </group>
        <group group_id="P2">
          <title>Trident Cup, X3 Inserts, 40 mm Head</title>
          <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 40 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Revision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Site terminated</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Trident Cup, X3 Inserts, 28 mm Head</title>
          <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 28 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
        </group>
        <group group_id="B2">
          <title>Trident Cup, X3 Inserts, 40 mm Head</title>
          <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 40 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.67" spread="4.68"/>
                    <measurement group_id="B2" value="62.91" spread="6.25"/>
                    <measurement group_id="B3" value="64.68" spread="5.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Data not available for all participants</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Netherlands</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>To Compare Wear of the Polyethylene X3 Insert Based on Digital Radiographs Using the Hip Analysis Suite (HAS).</title>
        <description>Determine equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes using HAS, a software for the determination of polyethylene wear on digital radiographs.</description>
        <time_frame>5 years follow-up</time_frame>
        <population>Wear data were not measured at the investigation site.</population>
        <group_list>
          <group group_id="O1">
            <title>Trident Cup, X3 Inserts, 28 mm Head</title>
            <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 28 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
          </group>
          <group group_id="O2">
            <title>Trident Cup, X3 Inserts, 40 mm Head</title>
            <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 40 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
          </group>
        </group_list>
        <measure>
          <title>To Compare Wear of the Polyethylene X3 Insert Based on Digital Radiographs Using the Hip Analysis Suite (HAS).</title>
          <description>Determine equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes using HAS, a software for the determination of polyethylene wear on digital radiographs.</description>
          <population>Wear data were not measured at the investigation site.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Harris Hip Score (HHS) Patient Questionnaire</title>
        <description>Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score of less than or equal to 79 is considered fair-poor. 90-100 = excellent 80-89 = good 70-79 = fair 0-69 = poor.</description>
        <time_frame>6 weeks, 3 months, 1, 2 and 5 years</time_frame>
        <population>Participants with available data. Overall number of participants analysed is based upon the 6 week population.</population>
        <group_list>
          <group group_id="O1">
            <title>Trident Cup, X3 Inserts, 28 mm Head</title>
            <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 28 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
          </group>
          <group group_id="O2">
            <title>Trident Cup, X3 Inserts, 40 mm Head</title>
            <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 40 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
          </group>
        </group_list>
        <measure>
          <title>Harris Hip Score (HHS) Patient Questionnaire</title>
          <description>Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score of less than or equal to 79 is considered fair-poor. 90-100 = excellent 80-89 = good 70-79 = fair 0-69 = poor.</description>
          <population>Participants with available data. Overall number of participants analysed is based upon the 6 week population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 weeks HHS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.89" spread="11.38"/>
                    <measurement group_id="O2" value="85.73" spread="7.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months HHS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.06" spread="12.03"/>
                    <measurement group_id="O2" value="92.60" spread="4.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year HHS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.71" spread="6.14"/>
                    <measurement group_id="O2" value="92.76" spread="4.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years HHS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.48" spread="6.05"/>
                    <measurement group_id="O2" value="92.63" spread="6.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 years HHS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.36" spread="6.56"/>
                    <measurement group_id="O2" value="85.95" spread="21.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Merle D'Aubergine Score (MdA)</title>
        <description>The Merle D'Aubergine-Charnley Score is a simplified clinical scoring system for the hip. The overall score is determined by the sum of scores obtained from each dimension of pain, walking ability and joint mobility. The overall numeric score is given by adding the domain scores. Clinical grades: Excellent, 18, Good 15-17, Fair 13-14, Poor &lt;13.</description>
        <time_frame>6 weeks, 3 months, 1, 2 and 5 years</time_frame>
        <population>Merle D'Aubergine Score (MdA) data were not measured at the investigation site.</population>
        <group_list>
          <group group_id="O1">
            <title>Trident Cup, X3 Inserts, 28 mm Head</title>
            <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 28 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
          </group>
          <group group_id="O2">
            <title>Trident Cup, X3 Inserts, 40 mm Head</title>
            <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 40 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
          </group>
        </group_list>
        <measure>
          <title>Merle D'Aubergine Score (MdA)</title>
          <description>The Merle D'Aubergine-Charnley Score is a simplified clinical scoring system for the hip. The overall score is determined by the sum of scores obtained from each dimension of pain, walking ability and joint mobility. The overall numeric score is given by adding the domain scores. Clinical grades: Excellent, 18, Good 15-17, Fair 13-14, Poor &lt;13.</description>
          <population>Merle D'Aubergine Score (MdA) data were not measured at the investigation site.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 5 years post-operative</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Trident Cup, X3 Inserts, 28 mm Head</title>
          <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 28 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
        </group>
        <group group_id="E2">
          <title>Trident Cup, X3 Inserts, 40 mm Head</title>
          <description>Equality of 5 year wear in the 28mm and the 40mm metal femoral head sizes. Trident cup in combination with Symax stem or Accolade TMZF stem.
Trident cup, X3 inserts, 40 mm head: Orthopaedic implant
Symax stem: Orthopaedic implant
Accolade TMZF stem: Orthopaedic implant</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Superficial infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Luxation of hip prosthesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Intraoperative Trochanter Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Bladder Tumor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Bowel Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Lung carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Doug McGurty</name_or_title>
      <organization>Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands</organization>
      <phone>+44 (0) 1635 500690</phone>
      <email>doug.mcgurty@stryker.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

